Diabetes research charity Juvenile Diabetes Research Foundation (JDRF) has published Our Impact 2021, “a glossy snapshot of everything JDRF achieved last year”, detailing how the
A set of policy recommendations have been drafted by the European Diabetes Forum (EUDF), emphasising the importance of digitalisation, data registries and integrated care to
In Type 1 diabetes, the body develops immune cells that target pancreatic beta cells, which play a critical role in the production and secretion of
Wrist-worn devices like smartwatches and fitness trackers appear to be cost-effective ways of screening for atrial fibrillation (AF) among high-risk people ages 65 and over,
Diabetes UK’s third annual Type 1 & Tech conference returns on Saturday 15 October 2022 from 10am to 2.30pm BST. The online conference, for people
Learning to ride a bike or getting out for a walk could soon be just what the doctor ordered under new health plans noted by
In a recent article in Medscape, Ania Jastreboff, MD, PhD explains how, when patients with obesity come to her, “I look for the opportunity to share
Metformin is the first drug prescribed to most new patients with Type 2 diabetes and is increasingly popular for use with patients with Type 1
Zillion has announced a partnership with Dexcom, a leading provider of real-time continuous glucose monitoring (CGM), to connect Dexcom CGM with Zillion’s platform for use
After receiving an FDA green light for the project earlier this year, Dexcom is now making its diabetes data available through consumer electronic devices. Leading
